ExodusPoint Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-115,785
| Closed | -$13.8M | – | 1767 |
|
|
2024
Q3 | $13.8M | Buy |
+115,785
| New | +$13.8M | 0.08% | 156 |
|
|
2023
Q3 | – | Sell |
-3,180
| Closed | -$257K | – | 1922 |
|
|
2023
Q2 | $257K | Sell |
3,180
-195,236
| -98% | -$15.8M | ﹤0.01% | 1512 |
|
|
2023
Q1 | $15.8M | Buy |
198,416
+58,696
| +42% | +$4.67M | 0.13% | 140 |
|
|
2022
Q4 | $9.46M | Buy |
139,720
+95,040
| +213% | +$6.43M | 0.14% | 177 |
|
|
2022
Q3 | $2.23M | Sell |
44,680
-303,472
| -87% | -$15.1M | 0.03% | 726 |
|
|
2022
Q2 | $19.4M | Buy |
348,152
+308,192
| +771% | +$17.2M | 0.24% | 66 |
|
|
2022
Q1 | $2.22M | Buy |
39,960
+23,074
| +137% | +$1.28M | 0.03% | 673 |
|
|
2021
Q4 | $946K | Buy |
+16,886
| New | +$946K | 0.01% | 1070 |
|
|
2021
Q2 | – | Sell |
-37,786
| Closed | -$1.27M | – | 2585 |
|
|
2021
Q1 | $1.27M | Buy |
37,786
+17,902
| +90% | +$604K | 0.02% | 743 |
|
|
2020
Q4 | $694K | Buy |
+19,884
| New | +$694K | 0.01% | 990 |
|
|
2020
Q3 | – | Sell |
-13,906
| Closed | -$455K | – | 2020 |
|
|
2020
Q2 | $455K | Buy |
13,906
+6,242
| +81% | +$204K | 0.01% | 1107 |
|
|
2020
Q1 | $231K | Buy |
+7,664
| New | +$231K | 0.01% | 693 |
|
|
2019
Q3 | – | Sell |
-65,960
| Closed | -$1.68M | – | 1509 |
|
|
2019
Q2 | $1.68M | Buy |
+65,960
| New | +$1.68M | 0.07% | 156 |
|